Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 5;9(1):e122.
doi: 10.15190/d.2021.1.

First COVID-19 Vaccines Receiving the US FDA and EMA Emergency Use Authorization

Andra Fortner  1 , David Schumacher  2
Affiliations
Review

First COVID-19 Vaccines Receiving the US FDA and EMA Emergency Use Authorization

Andra Fortner et al. Discoveries (Craiova). .

Abstract

On December 31, 2019, the Wuhan Municipal Health Commission reported an increase in the incidence of pneumonia from an unknown cause. Shortly after, SARS-CoV-19 was identified as the responsible coronavirus for the heavy progress of the disease, which can manifest itself distinctively in different individuals. Coronavirus Disease 2019 (COVID-19) triggered a pandemic because of its high contagiousness before COVID-19 associated symptoms actually appear. In response to the rapid and continuous spread of the virus around the globe governments have mobilized their forces to restrict contact and thus avoid further infection and invested significant resources in treatment and prevention strategies to tackle COVID-19. As a result, US FDA and EMA have granted emergency use authorization for two mRNA-based vaccines, namely the vaccines developed by BioNTech/Pfizer and Moderna, for use in the USA and Europe. Due to the existing critical situation, the stages of vaccine development and testing have probably never been gone through so fast as at present. Here, we are briefly commenting on these two vaccines with their benefits, advantages and limitations.

Keywords: COVID-19; European Medicines Agency.; US Food and Drug Administration; mRNA vaccine; vaccine.

PubMed Disclaimer

Conflict of interest statement

Conflict of interests: The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1. First two vaccines receiving emergency use authorization in Europe and the USA
Photo provided by dreamstime.com
See this image and copyright information in PMC

References

    1. WHO Coronavirus (COVID-19) Dashboard. WHO; Accessed: 2021 February 20. 2021. https://covid19.who.int/ https://covid19.who.int/
    1. COVID-19 VACCINE TRACKER. Data sourced from FasterCures, a center of the Milken Institute. Milken Institute COVID-19 Vaccine Tracker; Accessed: February 20, 2021. 2021. https://www.covid-19vaccinetracker.org/#Top-of-Page https://www.covid-19vaccinetracker.org/#Top-of-Page
    1. Next-generation vaccine platforms for COVID-19. van Riel Debby, de Wit Emmie. Nature Materials. 2020;19(8):810-812. - PubMed
    1. Die Corona-Impfstoffe von Biontech und Moderna im Vergleich. Rheinische Post; Accessed: 2021 January 7. 2021. https://rp-online.de/panorama/coronavirus/corona-impfstoff-biontech-und-... https://rp-online.de/panorama/coronavirus/corona-impfstoff-biontech-und-...
    1. Milken Institute COVID-19 Vaccine Tracker: Vaccines in Use. Covid-19 Vaccine Tracker; Accessed: February 20, 2021. 2021. https://www.covid-19vaccinetracker.org/authorized-vaccines https://www.covid-19vaccinetracker.org/authorized-vaccines

LinkOut - more resources